You have 9 free searches left this month | for more free features.

AUC(0-t)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

Upper Abdomen Imaging With Low Field MRI Scanner (0.4T)

Not yet recruiting
  • Abdominal Pain
  • Diagnostic MRI
  • (no location specified)
Sep 15, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)

Not yet recruiting
  • Aphakia
  • Clareon Vivity/Vivity Toric Extended Vision IOL
  • Clareon/Clareon Toric Aspheric IOL
  • Torrance, California
  • +6 more
May 2, 2023

EBV-positive Nasopharyngeal Carcinoma Trial in Guangzhou (Cohort A: 3.0x10^6 CAR-T cells/kg, Cohort B: 9.0x10^6CAR-T cells/kg,

Not yet recruiting
  • EBV-positive Nasopharyngeal Carcinoma
  • Cohort A: 3.0x10^6 CAR-T cells/kg
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 16, 2023

Bradycardia, Tachycardia, Heart Failure Trial (China market released 3.0T Magnetic resonance (MR) conditional CIED systems)

Not yet recruiting
  • Bradycardia
  • +2 more
  • China market released 3.0T Magnetic resonance (MR) conditional CIED systems
  • (no location specified)
Sep 12, 2023

Spondyloarthropathy, Tendinopathy Trial in Bordeaux (MRI ZTE2 sequence)

Recruiting
  • Spondyloarthropathy
  • Tendinopathy
  • MRI ZTE2 sequence
  • Bordeaux, France
    CHU de Bordeaux
Dec 26, 2022

Clareon IOL Retrospective Data Collection

Not yet recruiting
  • Aphakia
  • Astigmatism
  • Clareon UVA IOL
  • +2 more
  • Fort Worth, Texas
    Alcon Research, LLC
Mar 22, 2023

Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

Not yet recruiting
  • Multiple Myeloma
  • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
  • +3 more
  • (no location specified)
Jul 28, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy, distant lymph node 0.5Gy*4)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 6, 2022

Vancomycin, Adult, Area Under Curve Trial in Greenfield Park (Vancomycin dose adjustment using the Bayesian method, Vancomycin

Completed
  • Vancomycin
  • +2 more
  • Vancomycin dose adjustment using the Bayesian method
  • Vancomycin dose adjustment using the trough level method
  • Greenfield Park, Quebec, Canada
    Charles-Le Moyne Hospital
Sep 9, 2021

Breast Cancer Trial in Detroit (biological, drug, other)

Terminated
  • Breast Cancer
  • HER2Bi-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 29, 2022

Healthy Volunteers Trial in Newark (Bimatoprost Ophthalmic)

Not yet recruiting
  • Healthy Volunteers
  • Bimatoprost Ophthalmic
  • Newark, New Jersey
    Biotrial
Feb 6, 2023

Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)

Recruiting
  • Bronchial Cancer
    • Strasbourg, France
      Service de chirurgie thoracique - CHU de Strasbourg - France
    Oct 28, 2022

    Bioequivalence Trial in Chennai (Eszopiclone 3mg Test Drug T-1 Coated Tablets, Eszopiclone 3mg Test Drug T-2 Coated Tablets,

    Completed
    • Bioequivalence
    • Eszopiclone 3mg Test Drug T-1 Coated Tablets
    • +2 more
    • Chennai, Tamil Nadu, India
      Azidus Laboratories Ltd.
    Apr 22, 2022

    Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

    Not yet recruiting
    • Colonic Neoplasms
    • Dostarlimab
    • +2 more
    • (no location specified)
    May 3, 2023

    CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

    Recruiting
    • CAR T-Cell Therapy
    • HEC-016(0.5×10^6 CAR-T Cells)
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Luohu Hospital
    Mar 3, 2022

    Pressure Injury, Venous Leg Ulcer, Pressure Injury Stage 2 Trial in Calgary, Edmonton (NanoSALV Catalytic)

    Recruiting
    • Pressure Injury
    • +6 more
    • NanoSALV Catalytic
    • Calgary, Alberta, Canada
    • +3 more
    Jan 31, 2023

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

    Recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • Anakinra
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Cataract Trial in Trieste (ICB00 IOL, ZCB00 IOL, CNA0T0 IOL)

    Completed
    • Cataract
    • ICB00 IOL
    • +2 more
    • Trieste, Friuli Venezia Giulia, Italy
      University Eye Clinic of Trieste
    Oct 31, 2023

    Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal

    Recruiting
    • Larynx Cancer Stage I
    • Glottic Carcinoma
    • Hypofractionated single vocal cord irradiation
    • Whole laryngeal radiotherapy
    • Cairo, Egypt
      National Cancer Institute, Cairo University
    Jan 10, 2023

    Lung Graft Dysfunction Trial (Blood collection T0, Blood collection 6 months)

    Not yet recruiting
    • Lung Graft Dysfunction
    • Blood collection T0
    • Blood collection 6 months
    • (no location specified)
    Oct 27, 2023

    Acute Myeloid Leukemia Trial in Beijing (CI-135 CAR-T cells (0.5 x 10^6 CAR-T+ cells/kg,1.0 x 10^6 CAR-T+ cells/kg))

    Recruiting
    • Acute Myeloid Leukemia
    • CI-135 CAR-T cells (0.5 x 10^6 CAR-T+ cells/kg,1.0 x 10^6 CAR-T+ cells/kg)
    • Beijing, Beijing, China
      Beijing Gaobo Boren Hospital
    Feb 23, 2022